Delivery Order SPE2DR25D1200-SPE2DR26FMK2W
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $2,108.70. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,111.40 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on December 18, 2025, with an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,020.90 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on December 9, 2025, with completion scheduled for December 10, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its...
- The Defense Logistics Agency awarded a $5,189.93 delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 14, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,653.96 on January 5, 2026, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract to fulfill federal medical procurement requirements. The order is scheduled for completion by January 6, 2026, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $6,387.57. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 5, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, competitively awarded contract with a ceiling value of $1,354.88 and an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $2,427.99 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed-price delivery under a non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply chains, particularly supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,981.41 on November 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,112.07. This firm fixed-price contract, which is not set-aside and was competitively awarded, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D1200Indefinite Delivery Contract
- SPE2DR25D1200-SPE2DR26FMK2WDelivery Order
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $5,789.12 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The order, which is not set-aside, carries a firm fixed price and is expected to be completed by January 14, 2026. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the vehicle for military and federal healthcare pharmaceutical supply. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor supporting the Defense Health Agency and broader military healthcare systems globally through its parent company Cencora's comprehensive IDC. The delivery order for NovoLog insulin reflects the company's role in supplying essential diabetes management medications to federal medical programs. As a major pharmaceutical distributor, AmerisourceBergen competes on a full and open basis for federal contracts and has demonstrated consistent capability in fulfilling government procurement requirements for specialty medications, brand-name and generic drugs, vaccines, and other critical medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 1/12/26 |